← Open Payments lookup

RENEY FONTENOT: Open Payments

NPI 1295572774 · JENNINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$713 in 35 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $733 · 2025 $713

Food & beverage: $713
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$146
ABBVIE INC.13$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$121
Vanda Pharmaceuticals Inc.5$93
Axsome Therapeutics, Inc.3$65
Teva Pharmaceuticals USA, Inc.3$62
Indivior Inc.2$46
Otsuka America Pharmaceutical, Inc.1$16
Supernus Pharmaceuticals, Inc.1$15
Janssen Pharmaceuticals, Inc1$14

Products named: COBENFY, VRAYLAR, CAPLYTA, FANAPT, Auvelity, UZEDY, SUBLOCADE, HETLIOZ.

Industry payments across LA — which companies pay providers there.